Patient Recruitment / Close Clinical Trial

Patient Recruitment / Close Clinical Trial

A Recruitment Ongoing Studies

1 Ref No. “An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease                                                Dr. Naresh Somani
2 Multicentre, Double-Blind, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of Compared With Avastin®, in the First -line  treatment of Patient with Stage IV Non-Squamous Non-Small Cell Lung Cancer. (Phase –III)                                               Dr. Naresh Somani
3 Parachute: Pazopanib Real-world Assessment of Clinical effectiveness and safety in patients who have Undergone treatment in different settings in advanced renal cell carcinoma; a prospective, non-interventional, observation study (Phase-IV)                                                 Dr. Naresh Somani
4 A real-world, open-label, multi-center, prospective, non-interventional (observational) study to evaluate the effectiveness and tolerability of ceritinib in Indian patients with ALK positive metastatic non-small cell lung cancer who have progressed or are intolerant to crizotinib. (Phase-IV)                                           Dr. Naresh Somani
5 “A pilot study (Phase II Trial ) of Gefitinib/Afatinib With Pemetrexed as First-Line Therapy in Patients With Advanced Non-squamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations positive patients                                           Dr. Naresh Somani
6 A Phase II, Multicenter, Randomized, open Label, and Parallel Group Study to Evaluate Safety and Efficacy of endoxifen as First- Line Therapy in Women with Metastatic Estrogen Receptor Positive Breast Cancer (Phase-II)                                               Dr. Pawan Agarwal
7 Registry to compare effectiveness safety, and Resource Utilization of Rediux TM  vs the Reference Medicinal Product to Treat Diffuse Large B- Cell Lymphoma and Chronic Lymphocytic Leukaemia in Routine Clinical Practice (Phase-IV) Dr. Lalit Mohan Sharma
8 CANscriptTM Clinical Outcomes in a Real-World Setting : A Prospective, Multicenter, Observational Study Examining the Clinical Utility of CANscriptTM in Routine Clinical Practice (Phase-IV) Dr. Lalit Mohan Sharma
9 “A Multi-Centre, Randomized, Double Blind, Parallel-Group, Comparative Clinical Trial to evaluate the Safety and Clinical Equivalence of Generic Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) to Clotrimazole Troche/Lozenges ® 10mg (Roxane Laboratories Inc., USA) in subjects with Oropharyngeal Candidiasis”   Dr. Tejprakash Soni
10 “Post-Mastectomy Radiation Therapy in High Risk, Node Negative women with Early Breast Cancer (PMRT-NNBC) “                                          Dr. Nidhi Patni